DK2049079T3 - Sammensætninger, der indeholder kvaternære ammoniumforbindelser - Google Patents

Sammensætninger, der indeholder kvaternære ammoniumforbindelser

Info

Publication number
DK2049079T3
DK2049079T3 DK07787998.9T DK07787998T DK2049079T3 DK 2049079 T3 DK2049079 T3 DK 2049079T3 DK 07787998 T DK07787998 T DK 07787998T DK 2049079 T3 DK2049079 T3 DK 2049079T3
Authority
DK
Denmark
Prior art keywords
quaternary ammonium
compositions containing
ammonium compounds
containing quaternary
compounds
Prior art date
Application number
DK07787998.9T
Other languages
English (en)
Inventor
Laura Rabinovich-Guilatt
Gregory Lambert
Betty Philips
Frédéric Lallemand
Original Assignee
Santen Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65014357&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2049079(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/494,493 external-priority patent/US20080026013A1/en
Priority claimed from EP06291236.5A external-priority patent/EP1891939B1/en
Application filed by Santen Sas filed Critical Santen Sas
Application granted granted Critical
Publication of DK2049079T3 publication Critical patent/DK2049079T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62—Quaternary ammonium compounds
    • C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07787998.9T 2006-07-28 2007-07-27 Sammensætninger, der indeholder kvaternære ammoniumforbindelser DK2049079T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11/494,493 US20080026013A1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds
EP06291236.5A EP1891939B1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds
EP07112097 2007-07-09
PCT/IB2007/053441 WO2008035246A2 (en) 2006-07-28 2007-07-10 Compositions containing quaternary ammonium compounds
PCT/EP2007/057784 WO2008012367A2 (en) 2006-07-28 2007-07-27 Compositions containing quaternary ammonium compounds

Publications (1)

Publication Number Publication Date
DK2049079T3 true DK2049079T3 (da) 2017-01-02

Family

ID=65014357

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07787998.9T DK2049079T3 (da) 2006-07-28 2007-07-27 Sammensætninger, der indeholder kvaternære ammoniumforbindelser
DK11165011.5T DK2404593T3 (da) 2006-07-28 2007-07-27 Sammensætning omfattende kvaternære ammoniumforbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK11165011.5T DK2404593T3 (da) 2006-07-28 2007-07-27 Sammensætning omfattende kvaternære ammoniumforbindelser

Country Status (17)

Country Link
US (7) US7973081B2 (da)
EP (2) EP2404593B1 (da)
JP (1) JP5441058B2 (da)
KR (2) KR101507097B1 (da)
AU (1) AU2007278141B2 (da)
CA (1) CA2659322C (da)
CY (3) CY1118148T1 (da)
DK (2) DK2049079T3 (da)
ES (2) ES2586381T3 (da)
HU (2) HUE029987T2 (da)
IL (2) IL196740A (da)
LT (2) LT2049079T (da)
LU (1) LUC00006I2 (da)
PL (2) PL2404593T3 (da)
PT (2) PT2404593T (da)
SI (2) SI2404593T1 (da)
WO (2) WO2008035246A2 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
BRPI0912302A2 (pt) * 2008-05-28 2015-10-20 Alcon Res Ltd emulsões autopreservados
EP2228057A1 (en) * 2009-03-04 2010-09-15 Novagali Pharma S.A. Cationic oil-in-water emulsions containing prostaglandins and uses thereof
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
CA2760554A1 (en) * 2009-05-01 2010-11-04 Signal Investment And Management Co. Moisturizing antimicrobial composition
NO2437762T3 (da) 2009-06-05 2018-01-06
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
WO2013098841A1 (en) * 2011-10-31 2013-07-04 Fdc Limited Nanodispersion of poorly water soluble drug(s)
PL2787968T3 (pl) * 2011-12-07 2020-08-24 Allergan, Inc. Wydajne dostarczanie lipidów do ludzkiego filmu łzowego z użyciem wrażliwego na sól układu emulsyjnego
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
CA2947274C (en) * 2014-04-28 2019-03-19 Hampton Technologies Ophthalmic compositions and methods for treating eyes
US20160074178A1 (en) * 2014-09-17 2016-03-17 Van Phillips METHODS FOR PREPARING PRECISELY FITTED CASTS for PROSTHETICS
EP3011959A1 (en) * 2014-10-23 2016-04-27 Santen SAS Quaternary ammonium compound for use as an inhibitor of protein kinase C alpha
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
DK3266446T3 (da) * 2016-07-07 2019-02-11 Salvat Lab Sa Øjenpræparat omfattende ricinusolie og triglycerid med mediumkæde
EP3970692B1 (en) * 2020-09-18 2025-02-12 Omnivision GmbH Lipid-based ophthalmic composition for the treatment of dry eye
CN116390762B (zh) 2020-11-09 2026-05-08 思凯制药有限公司 固体环孢菌素a和包含其的分散组合物
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US20240009124A1 (en) * 2022-07-05 2024-01-11 Primera Compounding, LLC Ophthalmic Suspension Base having a Micro-fluidized Positively Charged Nanoparticle
KR20250073671A (ko) * 2022-09-28 2025-05-27 폴라로이드 아이피 비.브이. 항균 코팅 조성물
MX2025012492A (es) 2023-04-19 2026-02-03 Polaroid Therapeutics Ag Apositos para la cicatrizacion de heridas y formulaciones y metodos de uso de los mismos
US12600925B2 (en) 2023-04-21 2026-04-14 Reckitt Benckiser Llc Laundry sanitizing and softening compositions
WO2024226686A2 (en) * 2023-04-24 2024-10-31 Emory University Aminoadipate-semialdehyde synthase inhibitors and methods of treating cancer
TR2023007877A2 (tr) * 2023-07-06 2023-10-23 Ardi Farma Ilac Pazarlama Ticaret Ltd Sirketi Stabi̇l çoklu doz si̇klospori̇n yağ i̇çi̇nde su emülsi̇yon kompozi̇syonlari

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB633175A (en) * 1946-09-03 1949-12-12 Parke Davis & Co Antibiotic preparations and process for obtaining the same
USB724600I5 (da) * 1968-04-26
AU499860B2 (en) 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
JPH05116286A (ja) 1991-10-25 1993-05-14 Matsushita Electric Ind Co Ltd インク吐出装置
IL101241A (en) 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5496811A (en) 1992-08-28 1996-03-05 Pharmos Corp. Submicron emulsions as ocular drug delivery vehicles
IL103907A0 (en) * 1992-11-27 1993-04-04 Pharmos Corp Ophthalmic compositions
US5951988A (en) * 1993-03-30 1999-09-14 University Of Saskatchewan Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
ATE168553T1 (de) 1993-06-25 1998-08-15 Alcon Cusi S A Neue verwendung von polymeren membranen zum ausgeben von pharmazeutischen lösungen, die quarternäre, als konserviermittel dienende ammoniumverbindungen enthalten und entsprechender dosierbehälter
ATE227114T1 (de) * 1993-08-30 2002-11-15 Unilever Nv Haarwasch- und konditionierungsmittel
US5547990A (en) * 1994-05-20 1996-08-20 Lonza, Inc. Disinfectants and sanitizers with reduced eye irritation potential
AU687562B2 (en) 1994-05-20 1998-02-26 Novavax, Inc. Antimicrobial oil-in-water emulsions
US5435998A (en) * 1994-08-03 1995-07-25 Abelson; Mark B. Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5767153A (en) 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
TW446563B (en) * 1996-01-16 2001-07-21 Colgate Palmolive Co Low static conditioning shampoo
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
EP0878197B1 (en) 1997-05-14 2002-08-21 Senju Pharmaceutical Co., Ltd. Compositions containing difluprednate
US20020169138A1 (en) * 1997-10-24 2002-11-14 Southern Research Institute Delivery vehicles for bioactive agents and uses thereof
AU3548499A (en) 1998-04-02 1999-10-25 Schepens Eye Research Institute, Inc., The Corneal organ culture system for chemical toxicity tests of consumer products
FR2780879B1 (fr) * 1998-07-09 2002-09-20 Oreal Composition cosmetique photoprotectrice contenant un tensio-actif anionique, un compose filtrant le rayonnement ultraviolet et un compose cationique ou zwitterionique amphiphile et son utilisation
WO2000018316A2 (en) * 1998-09-25 2000-04-06 Alcon Laboratories, Inc. Sustained release, and comfortable ophthalmic composition and method for ocular therapy
US6030789A (en) 1999-03-10 2000-02-29 The Gillette Company Human conjunctival epithelial cell lines with an extended life span
US6635676B2 (en) 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
DE60006262T2 (de) * 1999-09-24 2004-05-13 Alcon, Inc. Topische suspensionsformulierungen enthaltend ciprofloxacin und dexamethason
PT1142566E (pt) 2000-04-07 2004-02-27 Medidom Lab Formulacao oftalmica topica na forma de uma solucao aquosa e uso de uma ciclosporina em associacao com acido hialuronico ou um de seus sais e com polisorbato 80
US20040033267A1 (en) 2002-03-20 2004-02-19 Elan Pharma International Ltd. Nanoparticulate compositions of angiogenesis inhibitors
WO2002096374A2 (en) * 2001-05-31 2002-12-05 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
EP2545937A1 (en) 2001-06-05 2013-01-16 The Regents Of The University Of Michigan Nanoemulsion vaccines
US6872705B2 (en) 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
EP1441696B1 (en) 2001-11-01 2010-05-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method and composition for dry eye treatment
US20030165545A1 (en) 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
JP5382972B2 (ja) 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
US20050175651A1 (en) 2004-01-09 2005-08-11 L'oreal Aqueous dispersion of nanocapsules with an oily core
US20050158349A1 (en) 2004-01-20 2005-07-21 Jampani Hanuman B. Two-phase compositions containing alcohol
EP1611879B1 (en) 2004-07-02 2009-08-12 Novagali Pharma SA Use of emulsions for intra- and periocular injection
CA2578176C (en) 2004-11-09 2013-09-24 Novagali Pharma Sa Ophthalmic emulsions containing an immunosuppressive agent
EP1655021B1 (en) 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
AU2007208169A1 (en) 2006-01-30 2007-08-02 Lawrence R. Bernstein Use of gallium to treat biofilm-associated infectons
US20080026013A1 (en) * 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
US20090018057A1 (en) * 2007-07-09 2009-01-15 Gregory Lambert OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES

Also Published As

Publication number Publication date
AU2007278141A1 (en) 2008-01-31
US11612658B2 (en) 2023-03-28
WO2008035246A2 (en) 2008-03-27
CA2659322A1 (en) 2008-01-31
KR20090047496A (ko) 2009-05-12
SI2049079T1 (sl) 2017-03-31
EP2049079B1 (en) 2016-09-07
HK1165993A1 (en) 2012-10-19
US9956289B2 (en) 2018-05-01
ES2586381T3 (es) 2016-10-14
US9220694B2 (en) 2015-12-29
KR101507465B1 (ko) 2015-03-31
AU2007278141B2 (en) 2014-01-16
CY1118148T1 (el) 2017-06-28
CY1118436T1 (el) 2017-06-28
EP2404593A1 (en) 2012-01-11
WO2008012367A2 (en) 2008-01-31
US20110201689A1 (en) 2011-08-18
WO2008012367A3 (en) 2008-05-29
US20190022231A1 (en) 2019-01-24
US20230181738A1 (en) 2023-06-15
HUE029987T2 (en) 2017-04-28
IL241753A0 (en) 2015-11-30
PT2404593T (pt) 2016-08-16
US20130337019A1 (en) 2013-12-19
PL2049079T3 (pl) 2017-03-31
IL196740A0 (en) 2009-11-18
SI2404593T1 (sl) 2016-11-30
US10842873B2 (en) 2020-11-24
PT2049079T (pt) 2016-12-09
US7973081B2 (en) 2011-07-05
PL2404593T3 (pl) 2016-11-30
JP2009544667A (ja) 2009-12-17
US20210038721A1 (en) 2021-02-11
IL241753B (en) 2018-03-29
JP5441058B2 (ja) 2014-03-12
LUC00006I2 (da) 2017-05-02
LUC00006I1 (da) 2017-02-28
CA2659322C (en) 2014-07-15
US8524779B2 (en) 2013-09-03
LTPA2017003I1 (lt) 2017-03-10
LT2049079T (lt) 2016-12-12
US20200000924A9 (en) 2020-01-02
KR20140041845A (ko) 2014-04-04
DK2404593T3 (da) 2016-08-29
HUE030841T2 (en) 2017-06-28
WO2008035246A3 (en) 2008-06-26
IL196740A (en) 2015-10-29
US20080026991A1 (en) 2008-01-31
EP2404593B1 (en) 2016-05-11
LTC2049079I2 (lt) 2019-12-27
US20160082107A1 (en) 2016-03-24
KR101507097B1 (ko) 2015-03-31
EP2049079A2 (en) 2009-04-22
ES2606467T3 (es) 2017-03-24
CY2017007I2 (el) 2017-06-28
CY2017007I1 (el) 2017-06-28

Similar Documents

Publication Publication Date Title
LTPA2017003I1 (lt) Kompozicijos, turinčios ketvirtinio amonio junginį
LTC2004635I2 (lt) Pakeistieji enaminokarbonilo junginiai
FR19C1035I2 (fr) Compositions fungicidal
BRPI0923786A2 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
PT2365754T (pt) Composições herbicidas contendo compostos de benzoilpirazole
HUS1700007I1 (hu) Kvaterner ammónium vegyületeket tartalmazó készítmények
EP2123654A4 (en) pyrazolopyrimidine compound
ATE502948T1 (de) Substituierte bicyclolactamverbindungen
ATE490254T1 (de) Imidazoä1,2-aüpyridin-verbindungen als vegf-r2- hemmer
EP2036901A4 (en) C-phenyl 1-thioglucitol compound
DK3275965T3 (da) Sammensætninger, der omfatter en fluorolefin
DK2414459T3 (da) Asfalt-mineral-sammensætninger, der indeholder en kationisk organosiliciumforbindelse
EP1985620A4 (en) 10a-azalide compound
CR10353A (es) Nuevos compuestos.
EP1876179A4 (en) THIENOPYRIMIDONVERBINDUNGEN
BRPI0814748A2 (pt) Compostos de alditóis substituídos, composições e métodos
ATE443056T1 (de) Substituierte n-sulfonylaminophenylethyl-2- phenoxyacetamidverbindungen
BRPI0916395A2 (pt) compostos de 1,6-di-hidro-2h-3-oxa-6-aza-as-indaceno
EP2206749A4 (en) phthalocyanine
EP2124549A4 (en) ANTIHYPERCHOLESTERINAMIC COMPOUNDS
DE502006006590D1 (de) Biozide zusammensetzungen
DE602006005232D1 (de) Konzentrierte Esterquat-zusammensetzung
EP1960358A4 (en) ANTINEOPLASTIC COMPOUNDS
ITMI20061291A1 (it) Composizioni (per) fluoroelastomeriche
DK1891939T3 (da) Sammensætninger indeholdende kvaternære ammoniumforbindelser